Skip to main content

OHSU Knight Cancer Institute

The Knight Cancer Institute at Oregon Health & Science University (OHSU) became an NCI-Designated Cancer Center in 1997 and was awarded comprehensive cancer center status in 2017. The Knight Cancer Institute is the only NCI-Designated Comprehensive Cancer Center between Sacramento and Seattle.

With its mission to end cancer as we know it, the institute is building on its groundbreaking expertise in targeted therapy to substantially improve outcomes for patients with advanced cancer and to enhance the ability to detect cancer at its earliest stages. From laboratory science to clinical trials of new treatments, to studying populations at risk, the institute’s scientists are advancing the understanding of the root causes of cancer and finding ways to improve detection, diagnosis, treatment, and prevention.

Read more about the OHSU Knight Cancer Institute. 

Oregon Health & Science University

Comp
Thomas A. Sellers, PhD, MPH
Director
3181 S.W. Same Jackson Park Rd., CR145
Portland, OR 97239-3098
(503) 494-1617
Mindy Roberts, MA
Associate Director of Administration
Jackilen Shannon, PhD, MPH
Associate Director, Community Outreach and Engagement
Grace Gill, PhD
Associate Director for Education and Training

Research Programs

Research Program Program Leaders
Cancer Biology Melissa Wong, PhD; Teresa Zimmers, PhD
Cancer Prevention and Control Sue Flocke, PhD
Quantitative Oncology Laura Heiser, PhD; Young Chang, PhD, MS, BS
Translational Oncology Jeffrey Tyner, PhD; Lara Davis, MD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Advanced Multiscale Microscopy Stefanie Kaech, PhD; Claudia Lopez, PhD
Cat 1: Laboratory Science Flow Cytometry Mike Munks, PhD
Cat 1: Laboratory Science Integrated Genomics Robert Searles, PhD
Cat 1: Laboratory Science Proteomics Ashok Reddy, PhD
Cat 4: Clinical Research BioLibrary and Pathology George Thomas, MD; Christopher Corless, MD, PhD
Cat 6: Biostatistics Biostatistics Byung Park, PhD
Last Updated
June 5, 2024